Viewing Company Aurora Cannabis | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Aurora Cannabis Stock Symbol: ACB-T

Last Price Recorded: $2.8200 on 2017-10-20

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-10-12 SPECULATIVE BUY Bruce Campbell (2)

He is excited about the cannabis industry worldwide.  They have been bringing on patients faster than anyone else.  It will be one of the largest cannabis greenhouses in the world.  He wants to see them execute on everything they said they would, going from a small facility to a large one.  See his top picks today.


Price:
$2.950
Subject:
CANADIAN
Bias:
OPTIMISTIC
Owned:
No
2017-08-31 COMMENT Chris Damas

It is one of his top 4 companies.  They have diluted their shares substantially.  They have over $100 million in debt.  They have the most upside and also the most downside.


Price:
$2.490
Subject:
Cannabis, Agriculture & Fertilizer
Bias:
BEARISH
Owned:
Unknown
2017-07-10 WEAK BUY Gerard Ferguson

They are moving to the big board.  It is probably the third Marijuana company to be listed on the TSX.  He thinks this won’t attract more investors internationally.  This is a step along the maturation phase for this company and for the industry.  This company also has a lot of convertible debt. 


Price:
$2.150
Subject:
CANADIAN
Bias:
SELECTIVE
Owned:
Unknown
2017-07-06 WATCH Chris Damas

A lot of the valuation will depend on whether they execute at their new facility.  He is warming up a bit to them.  They bought a company in Germany and they are also getting into hemp.  They are working with radiant technologies to see if their extracts plant can be used with cannabis. 


Price:
$2.140
Subject:
Cannabis, Agriculture & Fertilizer
Bias:
BEARISH
Owned:
Unknown
2017-06-22 DON'T BUY Bruce Campbell (2)

(Market Call Minute) Certainly not his top pick here.  They are building a massive operation in Alberta, however. 


Price:
$2.190
Subject:
CANADIAN & CANNABIS STOCKS
Bias:
BULLISH
Owned:
Unknown
2017-04-26 COMMENT Bruce Campbell (2)

The 2nd largest of all the cannabis producers. They have a plan to build an 800,000 ft.² facility in Edmonton, and it is fully funded. He understands they have some of the highest quality cannabis growing. They are also working on international expansion, which is an area that is really going to differentiate some of these companies.


Price:
$2.610
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
No
2017-04-11 COMMENT Cole Kachur

Marijuana stocks are tough to get a read on. They’ve all moved in a similar direction. He doesn’t know what the industry is going to look like or what the regulation is going to be like and how everything is going to play out. This is an industry in its infancy, but as a portfolio manager, it is not something he would look at. Once there is some clarification on what future legislation is going to look like, federally and provincially, then it will be a lot easier to determine which stocks are the ones to own.


Price:
$3.010
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Unknown
2017-03-10 COMMENT Bruce Campbell (2)

A cannabis company that has come roaring on to the scene. They were probably a little slower coming out of the gate than what you saw from a few of the others. This one is proposing a greenhouse project at the Edmonton International Airport, which is being billed as the world’s largest indoor cannabis grow when finished. They have about $150 million on their balance sheet now, that will be used to fund projects. Looking at valuation versus their licensed sales capacity, they are certainly ahead of the others from a valuation standpoint. As long as they continue to execute, it is probably going to be good, however the CEO tends to be a little on the promotional side. If you are a trader, take advantage by Selling when everybody loves it.


Price:
$2.390
Subject:
CANADIAN & CANNABIS STOCKS
Bias:
OPTIMISTIC
Owned:
Unknown
2017-02-24 DON'T BUY Andrey Omelchak

The whole industry has had a tremendous run, and everybody is excited about the prospects. It is still very difficult to size up and how much it can generate. There is a tremendous amount of speculation. You will be well suited, on a risk adjusted basis, to stay away from these companies for the time being, especially following the big run up they’ve had.


Price:
$2.620
Subject:
CANADIAN & HEDGING
Bias:
UNKNOWN
Owned:
Unknown
2017-02-15 COMMENT Colin Stewart

The whole medical/recreational marijuana industry is undergoing a lot of change. Most of that is legislative and we are seeing the development of a new industry that could be very large, but part of the challenge as an investor is trying to figure out what that means for these individual companies. Most of them don’t make much money or have a history of earnings. This is in the “too tough to figure out” category.


Price:
$2.560
Subject:
NORTH AMERICAN - LARGE (LONG/SHORT STRATEGIES)
Bias:
OPTIMISTIC
Owned:
No
2017-01-25 COMMENT Bruce Campbell (2)

Any time there is a bought deal financing, typically the stock trades down to that level, or in some cases even below it. Also, this is going to bounce around with the overall sector. For the whole cannabis space, they are not trading at cheap valuations. This company has a fairly small facility, but has raised a ton of money in the last few months to fund out their new expansion. There are a lot of execution risks.


Price:
$2.290
Subject:
CANADIAN
Bias:
BULLISH
Owned:
Unknown
2016-11-02 DON'T BUY Peter Hodson

Canopy Growth (CGC-T) or Aurora Cannabis (ACB-X)? He does not want to recommend either, but would take the larger Canopy over Aurora. There is no rational way of evaluating these on any fundamental basis, so you are buying them on the anticipation that someone else is going to pay more. A very, very dangerous game.


Price:
$2.090
Subject:
CANADIAN SMALL & MIDCAPS
Bias:
UNKNOWN
Owned:
No
2016-10-20 BUY James Hodgins

His favourite in the space.  They are being permitted to build the largest grow op in the world.  You are going to see some significant growth.  There are lots of catalysts in the space.  These guys have the best growth potential.  They purchased a clinic in Ontario and they intend to be vertically integrated.  They are the first one to do that strategy.


Price:
$2.240
Subject:
MARKET NEUTRAL INVESTING: SMALL/MID-CAP
Bias:
NEUTRAL
Owned:
Yes
Showing 1 to 13 of 13 entries

No Comments.


You must be logged in to comment.